Skip to content

DXL board chair steps in as CEO amid takeover pressure

The big-and-tall retailer's leadership shake-up comes as it fields a takeover approach and navigates the impact of weight-loss drugs on its core customer base.

10 August 2026

DXL Group, the big-and-tall menswear retailer, has seen its board chair step in as chief executive as the outgoing CEO retires, according to Retail Dive. The leadership change lands at a pressured moment for the company: it is understood to be considering a merger while simultaneously fighting off an unsolicited takeover offer, and grappling with the structural threat that GLP-1 weight-loss drugs pose to a business built around dressing larger-bodied men.

The weight-loss drug issue is the more consequential thread for the specialty retail sector generally. As GLP-1 medications reshape body sizes at a population level, retailers whose entire assortment and store format are built around plus-size fit face a genuine strategic problem, not just a marketing one. DXL's response to that shift, in merchandising, sizing curves and marketing, will be watched closely as a bellwether for adjacent apparel categories.

The combination of a leadership change, an active takeover approach and a demand-side disruption makes DXL a useful test case for how mid-sized specialty retailers navigate simultaneous financial and structural pressure. A rushed sale under a distracted board carries obvious risk, but so does prolonged uncertainty at the top while suitors circle.

What to watch: the identity and terms of any takeover bid, whether the new CEO signals a strategic pivot in sizing or category mix, and whether other plus-size-focused retailers begin flagging similar GLP-1-related pressure in their own results.

Support the content you love — it’s free 🎉

Add Worthbury as a preferred source on Google. Our stories will be more likely to appear in Google’s Top Stories. It’s free and supports our team. Thank you!

Add as preferred source

You can remove us any time in Google’s source preferences.

This briefing is published daily using an AI-powered system crafted by Worthbury's team and finely tuned to meet our editorial standards. While we continuously test and review the output, mistakes can sometimes happen. Tell us if you spot one.